

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0000013"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0000013" />

    <meta name="citation_title" content="Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice"/>
    <meta itemprop="name" content="Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice"/>

      <meta name="citation_author" content="Pia Leppänen"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Ivana Kholová"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Anssi J. Mähönen"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Kari Airenne"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Suvi Koota"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Hannu Mansukoski"/>
            <meta name="citation_author_institution" content="Technical University of Dresden, Dresden, Germany"/>
      <meta name="citation_author" content="Johanna Närväinen"/>
            <meta name="citation_author_institution" content="Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom"/>
      <meta name="citation_author" content="Maria Wirzenius"/>
            <meta name="citation_author_institution" content="Molecular/Cancer Biology Laboratory, Biomedicum, University of Helsinki, Helsinki, Finland"/>
      <meta name="citation_author" content="Leena Alhonen"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Juhani Jänne"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
      <meta name="citation_author" content="Kari Alitalo"/>
            <meta name="citation_author_institution" content="Molecular/Cancer Biology Laboratory, Biomedicum, University of Helsinki, Helsinki, Finland"/>
      <meta name="citation_author" content="Seppo Ylä-Herttuala"/>
            <meta name="citation_author_institution" content="Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland"/>
            <meta name="citation_author_institution" content="Department of Medicine and the Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland"/>

    <meta name="citation_date" content="2006/12/20"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0000013.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e13"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_volume" content="1"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.; citation_author=D Maglione; citation_author=V Guerriero; citation_author=G Viglietto; citation_author=P Delli-Bovi; citation_author=MG Persico; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=88; citation_number=1; citation_pages=9267-9271; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.; citation_author=V Joukov; citation_author=K Pajusola; citation_author=A Kaipainen; citation_author=D Chilov; citation_author=I Lahtinen; citation_author=E Kukk; citation_author=O Saksela; citation_author=N Kalkkinen; citation_author=KA Alitalo; citation_journal_title=EMBO J; citation_volume=15; citation_number=2; citation_pages=290-298; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=The biology of VEGF and its receptors.; citation_author=N Ferrara; citation_author=HP Gerber; citation_author=J LeCouter; citation_journal_title=Nat Med; citation_volume=9; citation_number=3; citation_pages=669-676; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Gene transfer as a tool to induce therapeutic vascular growth.; citation_author=S Ylä-Herttuala; citation_author=K Alitalo; citation_journal_title=Nat Med; citation_volume=9; citation_number=4; citation_pages=694-701; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.; citation_author=N Ferrara; citation_author=K Carver-Moore; citation_author=H Chen; citation_author=M Dowd; citation_author=L Lu; citation_author= O'Shea; citation_journal_title=Nature; citation_volume=380; citation_number=5; citation_pages=439-442; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.; citation_author=P Carmeliet; citation_author=V Ferreira; citation_author=G Breier; citation_author=S Pollefeyt; citation_author=L Kieckens; citation_journal_title=Nature; citation_volume=380; citation_number=6; citation_pages=435-439; citation_date=1996; " />
      <meta name="citation_reference" content="citation_title=Vegf is required for growth and survival in neonatal mice.; citation_author=H Gerber; citation_author=KJ Hillan; citation_author=AM Ryan; citation_author=J Kowalski; citation_author=G Keller; citation_journal_title=Development; citation_volume=126; citation_number=7; citation_pages=1149-1159; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.; citation_author=P Carmeliet; citation_author=YS Ng; citation_author=D Nuyens; citation_author=G Theilmeier; citation_author=K Brusselmans; citation_journal_title=Nat Med; citation_volume=5; citation_number=8; citation_pages=495-502; citation_date=1999; " />
      <meta name="citation_reference" content="citation_title=Model for gene therapy of human hereditary lymphedema.; citation_author=MJ Kärkkainen; citation_author=A Saaristo; citation_author=L Jussila; citation_author=KA Karila; citation_author=EC Lawrence; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=98; citation_number=9; citation_pages=12677-12682; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.; citation_author=MJ Kärkkainen; citation_author=P Haiko; citation_author=K Sainio; citation_author=J Partanen; citation_author=J Taipale; citation_journal_title=Nat Immunol; citation_volume=5; citation_number=10; citation_pages=74-80; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia.; citation_author=D Bellomo; citation_author=JP Headrick; citation_author=GU Silins; citation_author=CA Paterson; citation_author=PS Thomas; citation_journal_title=Circ Res; citation_volume=86; citation_number=11; citation_pages=E29-35; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.; citation_author=P Carmeliet; citation_author=L Moons; citation_author=A Luttun; citation_author=V Vincenti; citation_author=V Compernolle; citation_journal_title=Nat Med; citation_volume=7; citation_number=12; citation_pages=575-583; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Vascular endothelial growth factor D is dispensable for development of the lymphatic system.; citation_author=ME Baldwin; citation_author=MM Halford; citation_author=S Roufail; citation_author=RA Williams; citation_author=ML Hibbs; citation_journal_title=Mol Cell Biol; citation_volume=25; citation_number=13; citation_pages=2441-2449; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Massive inborn angiogenesis in the brain scarcely raises cerebral blood flow.; citation_author=J Vogel; citation_author=M Gehrig; citation_author=W Kuschinsky; citation_author=HH Marti; citation_journal_title=J Cereb Blood Flow Metab; citation_volume=24; citation_number=14; citation_pages=849-859; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice; citation_author=M Detmar; citation_author=LF Brown; citation_author=MP Schon; citation_author=BM Elicker; citation_author=P Velasco; citation_journal_title=J Invest Dermatol; citation_volume=111; citation_number=15; citation_pages=1-6; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo.; citation_author=X Zeng; citation_author=SE Wert; citation_author=R Federici; citation_author=KG Peters; citation_author=JA Whitsett; citation_journal_title=Dev Dyn; citation_volume=211; citation_number=16; citation_pages=215-227; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization; citation_author=N Okamoto; citation_author=T Tobe; citation_author=SF Hackett; citation_author=H Ozaki; citation_author=MA Vinores; citation_author= LaRochelle; citation_journal_title=Am J Pathol; citation_volume=151; citation_number=17; citation_pages=281-291; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.; citation_author=Y Dor; citation_author=V Djonov; citation_author=R Abramovitch; citation_author=A Itin; citation_author=GI Fishman; citation_journal_title=EMBO J; citation_volume=21; citation_number=18; citation_pages=1939-1947; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.; citation_author=T Odorisio; citation_author=C Schietroma; citation_author=ML Zaccaria; citation_author=F Cianfarani; citation_author=C Tiveron; citation_journal_title=J Cell Sci; citation_volume=115; citation_number=19; citation_pages=2559-2567; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.; citation_author=M Jeltsch; citation_author=A Kaipainen; citation_author=V Joukov; citation_author=X Meng; citation_author=M Lakso; citation_journal_title=Science; citation_volume=276; citation_number=20; citation_pages=1423-1425; citation_date=1997; " />
      <meta name="citation_reference" content="citation_title=Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.; citation_author=T Veikkola; citation_author=L Jussila; citation_author=T Makinen; citation_author=T Karpanen; citation_author=M Jeltsch; citation_journal_title=EMBO J; citation_volume=20; citation_number=21; citation_pages=1223-1231; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.; citation_author=SJ Mandriota; citation_author=L Jussila; citation_author=M Jeltsch; citation_author=A Compagni; citation_author=D Baetens; citation_journal_title=EMBO J; citation_volume=20; citation_number=22; citation_pages=672-682; citation_date=2001; " />
      <meta name="citation_reference" content="citation_title=Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia.; citation_author=M Laitinen; citation_author=K Mäkinen; citation_author=H Manninen; citation_author=P Matsi; citation_author=M Kossila; citation_journal_title=Hum Gene Ther; citation_volume=9; citation_number=23; citation_pages=1481-1486; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses.; citation_author=AM Puumalainen; citation_author=M Vapalahti; citation_author=RS Agrawal; citation_author=M Kossila; citation_author=J Laukkanen; citation_journal_title=Hum Gene Ther; citation_volume=9; citation_number=24; citation_pages=1769-1774; citation_date=1998; " />
      <meta name="citation_reference" content="citation_title=Site-specific recombinases: tools for genome engineering.; citation_author=NJ Kilby; citation_author=MR Snaith; citation_author=JA Murray; citation_journal_title=Trends Genet; citation_volume=9; citation_number=25; citation_pages=413-21; citation_date=1993; " />
      <meta name="citation_reference" content="citation_title=Gene transfers of VEGF-A, VEGF-B, VEGF-C and VEGF-D have no effects on atherosclerosis in hypercholesterolemic LDL-receptor/ApoB48- deficient mice.; citation_author=P Leppänen; citation_author=S Koota; citation_author=I Kholová; citation_author=J Koponen; citation_author=C Fieber; citation_journal_title=Circulation; citation_volume=112; citation_number=26; citation_pages=1347-1352; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods.; citation_author=MO Hiltunen; citation_author=MP Turunen; citation_author=AM Turunen; citation_author=T Rissanen; citation_author=M Ruuskanen; citation_journal_title=FASEB J; citation_volume=14; citation_number=27; citation_pages=2230-2236; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Cardiovascular gene therapy.; citation_author=S Ylä-Herttuala; citation_author=JF Martin; citation_journal_title=Lancet; citation_volume=355; citation_number=28; citation_pages=213-22; citation_date=2000; " />
      <meta name="citation_reference" content="citation_title=Conditional and indusible transgene expression in mice through combinatorial use of cre-mediated recombination and tetracycline induction.; citation_author=G Belteki; citation_author=J Haigh; citation_author=N Kabacs; citation_author=K Haigh; citation_author=K Sison; citation_journal_title=Nucleic Acid Res; citation_volume=33; citation_number=29; citation_pages=E51; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Angiogenesis-independent endothelial protection of liver: role of VEGFR-1.; citation_author=J LeCouter; citation_author=DR Moritz; citation_author=B Li; citation_author=GL Phillips; citation_author=XH Liang; citation_journal_title=Science; citation_volume=299; citation_number=30; citation_pages=890-893; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo.; citation_author=MO Hiltunen; citation_author=M Ruuskanen; citation_author=J Huuskonen; citation_author=AJ Mähönen; citation_author=M Ahonen; citation_journal_title=FASEB J; citation_volume=17; citation_number=31; citation_pages=1147-1149; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas in several strains of mice.; citation_author=CH Frith; citation_author=L Wiley; citation_journal_title=Lab Lab Anim Sci; citation_volume=32; citation_number=32; citation_pages=157-62; citation_date=1982; " />
      <meta name="citation_reference" content="citation_title=Targeted oncogene activation by site-specific recombination in transgenic mice.; citation_author=M Lakso; citation_author=B Sauer; citation_author=B Mosinger; citation_author=EJ Lee; citation_author=RW Manning; citation_journal_title=Proc Natl Acad Sci USA; citation_volume=89; citation_number=33; citation_pages=6232-6236; citation_date=1992; " />
      <meta name="citation_reference" content="citation_title=Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice.; citation_author=J Jalkanen; citation_author=P Leppänen; citation_author=O Narvanen; citation_author=DR Greaves; citation_author=S Ylä-Herttuala; citation_journal_title=Atherosclerosis; citation_volume=169; citation_number=34; citation_pages=95-103; citation_date=2003; " />
      <meta name="citation_reference" content="citation_title=Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.; citation_author=C Cursiefen; citation_author=U Schlotzer-Schrehardt; citation_author=M Kuchle; citation_author=L Sorokin; citation_author=S Breiteneder-Geleff; citation_journal_title=Invest Ophthalmol Vis Sci; citation_volume=43; citation_number=35; citation_pages=2127-2135; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial Tissue.; citation_author=S Bhardwaj; citation_author=H Roy; citation_author=M Gruchala; citation_author=H Viita; citation_author=I Kholova; citation_journal_title=Hum Gene Ther; citation_volume=14; citation_number=36; citation_pages=1451-1462; citation_date=2003; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice"/>
    <meta name="twitter:description" content="We have generated a transgenic mouse where hVEGF-A165 expression has been silenced with loxP-STOP fragment, and we used this model to study the effects of hVEGF-A165 over-expression in mice after systemic adenovirus mediated Cre-gene transfer. Unlike previous conventional transgenic models, this model leads to the expression of hVEGF-A165 in only a low number of cells in the target tissues in adult mice. Levels of hVEGF-A165 expression were moderate and morphological changes were found mainly in the liver, showing typical signs of active angiogenesis. Most mice were healthy without any major consequences up to 18 months after the activation of hVEGF-A165 expression. However, one mouse with a high plasma hVEGF-A165 level died spontaneously because of bleeding into abdominal cavity and having liver hemangioma, haemorrhagic paratubarian cystic lesions and spleen peliosis. Also, two mice developed malignant tumors (hepatocellular carcinoma and lung adenocarcinoma), which were not seen in control mice. We conclude that long-term uncontrolled hVEGF-A165 expression in only a limited number of target cells in adult mice can be associated with pathological changes, including possible formation of malignant tumors and uncontrolled bleeding in target tissues. These findings have implications for the design of long-term clinical trials using hVEGF-A165 gene and protein."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0000013.g006"/>

  <meta property="og:title" content="Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=3054'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=8747'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=9064&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0000013">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000013" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000013&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Short and Long-Term Effects of hVEGF-A<sub>165</sub> in Cre-Activated Transgenic Mice
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Pia Leppänen, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Ivana Kholová, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Anssi J. Mähönen, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Kari Airenne, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Suvi Koota, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Hannu Mansukoski, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Technical University of Dresden, Dresden, Germany
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Johanna Närväinen, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Maria Wirzenius, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Molecular/Cancer Biology Laboratory, Biomedicum, University of Helsinki, Helsinki, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Leena Alhonen, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Juhani Jänne, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Kari Alitalo, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Molecular/Cancer Biology Laboratory, Biomedicum, University of Helsinki, Helsinki, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Seppo Ylä-Herttuala
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:Seppo.Ylaherttuala@uku.fi">Seppo.Ylaherttuala@uku.fi</a>
            </p>

                <p>Affiliations:
                  Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Kuopio, Kuopio, Finland, 
                  Department of Medicine and the Gene Therapy Unit, Kuopio University Hospital, Kuopio, Finland
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: December 20, 2006</li>
    <li>DOI: 10.1371/journal.pone.0000013</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0000013-g001" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-g002" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-g003" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-t001" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.t001" title="Table 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.t001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-t002" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.t002" title="">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.t002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-g004" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-g005" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g005" title="Figure 5">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g005&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0000013-g006" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g006" title="Figure 6">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g006&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0000013">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0000013" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>We have generated a transgenic mouse where hVEGF-A<sub>165</sub> expression has been silenced with loxP-STOP fragment, and we used this model to study the effects of hVEGF-A<sub>165</sub> over-expression in mice after systemic adenovirus mediated Cre-gene transfer. Unlike previous conventional transgenic models, this model leads to the expression of hVEGF-A<sub>165</sub> in only a low number of cells in the target tissues in adult mice. Levels of hVEGF-A<sub>165</sub> expression were moderate and morphological changes were found mainly in the liver, showing typical signs of active angiogenesis. Most mice were healthy without any major consequences up to 18 months after the activation of hVEGF-A<sub>165</sub> expression. However, one mouse with a high plasma hVEGF-A<sub>165</sub> level died spontaneously because of bleeding into abdominal cavity and having liver hemangioma, haemorrhagic paratubarian cystic lesions and spleen peliosis. Also, two mice developed malignant tumors (hepatocellular carcinoma and lung adenocarcinoma), which were not seen in control mice. We conclude that long-term uncontrolled hVEGF-A<sub>165</sub> expression in only a limited number of target cells in adult mice can be associated with pathological changes, including possible formation of malignant tumors and uncontrolled bleeding in target tissues. These findings have implications for the design of long-term clinical trials using hVEGF-A<sub>165</sub> gene and protein.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Leppänen P, Kholová I, Mähönen AJ, Airenne K, Koota S, et al.  (2006) Short and Long-Term Effects of hVEGF-A<sub>165</sub> in Cre-Activated Transgenic Mice. PLoS ONE 1(1):
          e13.
            doi:10.1371/journal.pone.0000013</p><p><strong>Academic Editor: </strong>Mihail Blagosklonny, Ordway Research Institute Inc., United States of America</p><p><strong>Received:</strong> August 21, 2006; <strong>Accepted:</strong> September 2, 2006; <strong>Published:</strong> December 20, 2006</p><p><strong>Copyright:</strong> © 2006 Leppänen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was supported by grants from Sigrid Juselius Foundation, Finnish Foundation for Cardiovascular Research, Finnish Academy and European Union (Lymphangiogenenomics LSHG-CT-2004-503573) and European Vascular Genomics Network (EVGN, LSHM-CT-2003-503254).</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>Vascular endothelial growth factor (VEGF-A) was the first identified member of the family that now includes placental growth factor (PIGF) and several other VEGFs (VEGF-B,-C,-D,-E) <a href="#pone.0000013-Maglione1">[1]</a>, <a href="#pone.0000013-Joukov1">[2]</a>. Since then the VEGF family has been shown to play a major role in vascular permeability, angiogenesis and lymphangiogenesis both during embryonic development and in adults. VEGFs have also been used in clinical applications as recombinant proteins or gene therapy <a href="#pone.0000013-Ferrara1">[3]</a>, <a href="#pone.0000013-YlHerttuala1">[4]</a>. However, long term effects of moderate VEGF over-expression in adults have not been characterized in the context of recombinant protein or gene therapy.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>Due to the fundamental requirement of VEGF-A in embryonal development it has been impossible to create viable knockout models for VEGF-A. Even by knockout of a single VEGF-A allele mice were unable to survive <a href="#pone.0000013-Ferrara2">[5]</a>–<a href="#pone.0000013-Gerber1">[7]</a>. Also, mice expressing only VEGF-A<sub>120</sub> but no longer isoforms die within two weeks after birth because of the cardiac failure <a href="#pone.0000013-Carmeliet2">[8]</a>. VEGF-C knockout mice die due to the lack of lymphatic vessels, while VEGF-C+/− mice survive despite of the defects in lymphatic vessels [9.10]. In contrast to VEGF-A and VEGF-C knockout mice VEGF-B, VEGF-D and PIGF deficient mice are viable, and PIGF and VEGF-B double-knockout mice showed no significant vascular phenotype <a href="#pone.0000013-Bellomo1">[11]</a>–<a href="#pone.0000013-Baldwin1">[13]</a>. Several transgenic mouse models have been generated using the members of the VEGF family. Transgenic VEGF-A has been expressed in the skin, eyes, lungs, heart or liver under tissue specific promoters <a href="#pone.0000013-Vogel1">[14]</a>–<a href="#pone.0000013-Dor1">[18]</a>. Also, PIGF transgenic mice have been described <a href="#pone.0000013-Odorisio1">[19]</a>. Similar results have been reported from these models, showing that all mice have increased vascularization and vascular permeability. In contrast, studies with transgenic mice over-expressing VEGF-C and VEGF-D under keratinocyte or pancreas specific promoters have demonstrated the role of these growth factors mainly in lymphangiogenesis <a href="#pone.0000013-Jeltsch1">[20]</a>–<a href="#pone.0000013-Mandriota1">[22]</a>. However, in all these models VEGFs are typically expressed in every cell of the target tissue and the models may not fully predict outcome after gene therapy applications where transduction efficiency is typically &lt;1–5% of the cells in target organ <a href="#pone.0000013-Laitinen1">[23]</a>, <a href="#pone.0000013-Puumalainen1">[24]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>We have generated a transgenic mouse model containing in its genome a loxP-STOP inactivated hVEGF-A<sub>165</sub> expression cassette, which can be activated by Cre gene transfer in any tissue at any point during life <a href="#pone.0000013-Kilby1">[25]</a>. The main reason for the generation of the current transgenic model was to evaluate potential long-term side effects of therapeutic hVEGF-A<sub>165</sub> gene transfer. In this construct we have used the same type of enhancer as we have used in our previous gene transfer studies, but employed a more methylation-resistant promoter in order to achieve a long-term expression (CMV immediate early enhancer and the chicken β–actin promoter) <a href="#pone.0000013-Laitinen1">[23]</a>, <a href="#pone.0000013-Leppnen1">[26]</a>. In the present study we have used this mouse model to study short and long-term effects of hVEGF-A<sub>165</sub> over-expression on the pathology of liver and various other tissues. Systemic AdCre gene transfer was chosen for the study since this leads primarily to the activation of hVEGF-A<sub>165</sub> in the liver, which is the most common site of unintended biodistribution of adenoviruses after in vivo gene transfer <a href="#pone.0000013-Hiltunen1">[27]</a>, <a href="#pone.0000013-YlHerttuala2">[28]</a>.</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Results and Discussion"></a><h3>Results and Discussion</h3>
<h4>Testing of the hVEGF-A<sub>165</sub> expression cassette and Short-term effects</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>Before creating transgenic mice the pFlox construct (<a href="#pone-0000013-g001">Figure 1</a>) was tested in vitro and the cassette was found functional causing a strong hVEGF-A<sub>165</sub> expression after AdCre-mediated excision of the STOP fragment. AdCre and pFlox treated cells expressed hVEGF-A<sub>165</sub> efficiently reaching the peak expression at 24 h after the transduction. Cells transduced with pFlox alone or hVEGF-A<sub>165</sub> transgenic mice without gene transfer did not express any detectable amounts of hVEGF-A<sub>165</sub> during the follow-up time. The functionality of the hVEGF-A<sub>165</sub> transgene in vivo was verified by MRI, where typical changes were seen as discrete edema localized under the skin in all transduced muscles and their fascia and also in the fat tissue due to increased vessel permeability (<a href="#pone-0000013-g002">Figure 2</a> and <a href="#pone-0000013-t001">Table 1A</a>). We used ELISA to measure the levels of hVEGF-A<sub>165</sub> in order to see total protein levels of the transgene both in sera and tissues. The possible gross-reactivity was tested after local gene transfer and no correlations were found between mouse endogenous VEGF-A<sub>164</sub> and hVEGF-A<sub>165</sub> levels in the control and the AdCre transduced transgenic mice (<a href="#pone-0000013-g002">Figure 2</a>). Systemic AdCre gene transfer via tail vein was done to 31 transgenic mice and 10 control mice at the age of 2 months. Also, 10 additional transgenic mice were injected with saline or AdLacZ. One week after activation a wide range of hVEGF-A<sub>165</sub> concentrations were detected in sera of the transgenic mice. We estimate that only 0.1 to 5% of all cells in the liver were transduced after the AdCre gene transfer and the levels of hVEGF-A<sub>165</sub> were only moderate in comparison to the transgene expression levels achieved in tissues in previously generated transgenic VEGF-A models where all cells in a given tissue express the transgene. For example Dor et al <a href="#pone.0000013-Dor1">[18]</a> were able to achieve 7- to 11-fold increases in hVEGF-A<sub>165</sub> expression as compared with the level of endogenous mVEGF-A<sub>164</sub> After 1 week the levels of hVEGF-A<sub>165</sub> in serum were ~50% of the levels achieved after direct gene transfer with adenoviruses encoding hVEGF-A<sub>165</sub> 
               <a href="#pone.0000013-Leppnen1">[26]</a>. During the next 3–4 weeks (<a href="#pone-0000013-g003">Figure 3A</a>) serum hVEGF-A<sub>165</sub> levels decreased. This could be due to the immune response against adenovirus or toxicity of Cre, even if no signs of pathological responses were found in clinical chemistry or histological sections; apoptotic cells were present in all livers transduced with AdCre, but also in the control mice (data not shown) and no major abnormalities were seen (ASAT and CRP) between the groups (<a href="#pone-0000013-g003">Figure 3B and C</a>). The promoter area was selected to be more resistant to methylation (the chicken β–actin promoter) and in contrast to serum levels, low expression of hVEGF-A<sub>165</sub> was present in many tissues even after 18 months as analyzed with ELISA (<a href="#pone-0000013-t001"></a>
               <a href="#pone-0000013-t001">Table 1</a>) and RT-PCR (<a href="#pone-0000013-g003">Figure 3D</a>).</p>
<div class="figure" id="pone-0000013-g001"><div class="img"><a name="pone-0000013-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Shematic representation of pFlox hVEGF-A<sub>165</sub> cassette, where VEGF expression is activated by Cre-mediated excision of STOP cassette and expression of human hVEGF-A<sub>165</sub> in vitro after AdCre mediated transduction of NIH-3T3 cells with plasmid loxP-STOP-hVEGF-A<sub>165</sub>. CAG = CMV-IE enhancer+chicken β-actin promoter; triangle = loxP, a 34 bp long recombination sequence; STOP = DNA element to prevent VEGF expression; hVEGF-A = human VEGF-A<sub>165</sub> cDNA; pA = rabbit β-globin polyadenylation signal.</span></strong></p><span>doi:10.1371/journal.pone.0000013.g001</span></div><div class="figure" id="pone-0000013-g002"><div class="img"><a name="pone-0000013-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Edema after AdCre mediated local gene transfer detected by MRI and results from human and mouse ELISA analyses after local GT. Discrete edema (white areas pointed with arrows) is clearly visible between day 1 and day 7 under the skin in T2 weighted MRI images in the transduced leg muscles, their fascias, and in the fat tissue within the transduced muscles.</span></strong></p><a id="article1.body1.sec2.sec1.fig2.caption1.p1" name="article1.body1.sec2.sec1.fig2.caption1.p1"></a><p>ELISA assays were done as described in the <a href="#s3">Methods</a>.</p>
<span>doi:10.1371/journal.pone.0000013.g002</span></div><div class="figure" id="pone-0000013-g003"><div class="img"><a name="pone-0000013-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Expression of human and mouse VEGF-A after AdCre gene transfer in vivo.</span></strong></p><a id="article1.body1.sec2.sec1.fig3.caption1.p1" name="article1.body1.sec2.sec1.fig3.caption1.p1"></a><p>A. hVEGF-A<sub>165</sub> ELISA from sera after AdCre gene transfer.</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p2" name="article1.body1.sec2.sec1.fig3.caption1.p2"></a><p>B. ASAT values in transgenic and control mice after AdCre gene transfer.</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p3" name="article1.body1.sec2.sec1.fig3.caption1.p3"></a><p>C. CRP values in transgenic and control mice after AdCre gene transfer.</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p4" name="article1.body1.sec2.sec1.fig3.caption1.p4"></a><p>D. Expression of hVEGF-A<sub>165</sub> mRNA using RT-PCR.</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p5" name="article1.body1.sec2.sec1.fig3.caption1.p5"></a><p>Lanes; 1 = Aorta, 2 = pancreas, 3 = kidney, 4 = heart, 5 = spleen, 6 = liver, 7 = positive control and 8 = liver without RT (500 bp pointed with an arrow).</p>
<a id="article1.body1.sec2.sec1.fig3.caption1.p6" name="article1.body1.sec2.sec1.fig3.caption1.p6"></a><p>&lt;500 and &gt;500 in B and C refer to hVEGF-A<sub>165</sub> serum levels in two subgroups of transgenic mice.</p>
<span>doi:10.1371/journal.pone.0000013.g003</span></div><div class="figure" id="pone-0000013-t001"><div class="img"><a name="pone-0000013-t001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.t001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.t001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.t001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.t001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.t001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.t001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.t001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.t001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.t001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.t001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.t001.TIF"></span>)
                </a></li></ul></div><p><strong>Table 1.  <span>A. Human and mouse VEGF-A ELISAs (pmol/mg) from tissue samples after systemic AdCre gene transfer (mean+/−SD)</span></strong></p><span>doi:10.1371/journal.pone.0000013.t001</span></div><div class="figure" id="pone-0000013-t002"><div class="img"><a name="pone-0000013-t002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.t002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.t002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.t002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.t002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.t002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.t002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.t002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.t002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.t002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.t002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.t002.TIF"></span>)
                </a></li></ul></div><p><strong> <span>B. Summary of morphological changes in tissues after activation of hVEGF-A165 expression.</span></strong></p><span>doi:10.1371/journal.pone.0000013.t002</span></div><a id="article1.body1.sec2.sec1.p2" name="article1.body1.sec2.sec1.p2"></a><p>Adenoviral gene expression after systemic gene transfer is typically seen in the liver, heart, kidneys, spleen and lungs <a href="#pone.0000013-Hiltunen1">[27]</a>. Accordingly, changes in histology after hVEGF-A<sub>165</sub> expression were seen in the liver, heart and spleen in most mice, but usually not in the lungs or in the kidneys (<a href="#pone-0000013-t001"></a>
               <a href="#pone-0000013-t002">Table 1</a>). This can be explained by comparison of the human and mouse endogenous VEGF-A protein levels in different tissues. In the lungs the maximal hVEGF-A<sub>165</sub> protein expression levels were only 2–8% of the mVEGF-A<sub>164</sub> levels and in the kidneys hVEGF-A<sub>165</sub> protein expression rapidly decreased to low or undetectable levels. At the early time points, 1–4 weeks after the AdCre gene transfer, histopathological changes were found only in the livers (<a href="#pone-0000013-g004">Figure 4A–C</a>). An increased number of capillaries featured active angiogenesis: formation of glomeruloid bodies, increased sprouting and branching, sac-like structures and focal hemangioma-like structures (<a href="#pone-0000013-g004">Figure 4C</a>). The number of capillaries correlated with the number of proliferating hepatocytes (PCNA positive nuclei) and the expression levels of hVEGF-A<sub>165</sub> (<a href="#pone-0000013-g004">Figure 4D</a>). Similar results have been seen in transgenic mice which express hVEGF-A<sub>165</sub> in the liver <a href="#pone.0000013-Dor1">[18]</a>, <a href="#pone.0000013-Belteki1">[29]</a>–<a href="#pone.0000013-LeCouter1">[30]</a>.</p>
<div class="figure" id="pone-0000013-g004"><div class="img"><a name="pone-0000013-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Short term histopathological changes in the liver four weeks after gene transfer.</span></strong></p><a id="article1.body1.sec2.sec1.fig4.caption1.p1" name="article1.body1.sec2.sec1.fig4.caption1.p1"></a><p>A. Increased number of capillaries showing branching and sprouting (CD 34 immunostaining).</p>
<a id="article1.body1.sec2.sec1.fig4.caption1.p2" name="article1.body1.sec2.sec1.fig4.caption1.p2"></a><p>Insert: PCNA immunostaining in nuclei correlated positively with the degree of angiogenesis.</p>
<a id="article1.body1.sec2.sec1.fig4.caption1.p3" name="article1.body1.sec2.sec1.fig4.caption1.p3"></a><p>B. Control liver only revealed weak positivity in hepatic vein branches (CD 34 immunostaining).</p>
<a id="article1.body1.sec2.sec1.fig4.caption1.p4" name="article1.body1.sec2.sec1.fig4.caption1.p4"></a><p>C. Details of neovascularization in the liver: formation of glomeruloid bodies and enhanced sprouting and branching (pointed with arrows, CD 34 immunostaining).</p>
<a id="article1.body1.sec2.sec1.fig4.caption1.p5" name="article1.body1.sec2.sec1.fig4.caption1.p5"></a><p>D. Vascularization and proliferation in livers after AdCre gene transfer.</p>
<a id="article1.body1.sec2.sec1.fig4.caption1.p6" name="article1.body1.sec2.sec1.fig4.caption1.p6"></a><p>ELISA values refer to two subgroups of mice with low and high hVEGF-A<sub>165</sub> levels in serum.</p>
<a id="article1.body1.sec2.sec1.fig4.caption1.p7" name="article1.body1.sec2.sec1.fig4.caption1.p7"></a><p>Bar: A insert, C–50 µm; B–100 µm. GT: gene transfer, cap/mm<sup>2</sup>: capillaries/mm<sup>2</sup>, NF: not found, * p&lt;0,05.</p>
<span>doi:10.1371/journal.pone.0000013.g004</span></div>

<h4>Long-terms effect of hVEGF-A<sub>165</sub>
            </h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>Within 6–18 months after the AdCre gene transfer increased vascularization and proliferation of hepatocytes persisted in the livers, but morphological abnormalities and signs of active angiogenesis were less common (<a href="#pone-0000013-g005">Figure 5A</a>). All mice were healthy without any major consequences up to 13 months and only minor changes were seen: Out of 19 mice in the long-term follow-up group one mouse had a hepatic focal basophilic hyperplasia of 500 µm in diameter containing cells with a high amount of fat (<a href="#pone-0000013-g005">Figure 5B</a>). In heart, we found discrete edema and in two mice epicardial calcification was present (<a href="#pone-0000013-g005">Figure 5C, E</a>), which can be explained by hVEGF-A<sub>165</sub> capacity to increase bone formation <a href="#pone.0000013-Hiltunen2">[31]</a>. In one mouse the fallopian tube was highly vascularized (<a href="#pone-0000013-g005">Figure 5F</a>) and in other mouse increased vascularization, occasional focal fibrosis and paraductal lymphocytic infiltration was found in pancreas. Also, testis of the same mouse was highly vascularized (<a href="#pone-0000013-g005">Figure 5G–J</a>). No changes were found in ovaries and kidneys. Generally, all angiogenic changes were found at the level of capillaries and arterioles/venules and featured increased number of vessels, enlargement of vessels and local angiogenic activity.</p>
<div class="figure" id="pone-0000013-g005"><div class="img"><a name="pone-0000013-g005" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g005&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g005"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g005&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g005/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g005/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g005/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g005/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g005.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g005/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g005/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g005.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 5.  <span>Long-term histopathological changes after activation of hVEGF-A<sub>165</sub> expression.</span></strong></p><a id="article1.body1.sec2.sec2.fig1.caption1.p1" name="article1.body1.sec2.sec2.fig1.caption1.p1"></a><p>A. Liver: Dilated hepatic vein branches and mild dilatation of the sinuses (marked with *) (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p2" name="article1.body1.sec2.sec2.fig1.caption1.p2"></a><p>B. Liver: focal basophilic hyperplasia consisting of fat-filled hepatocytes (pointed with arrows), (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p3" name="article1.body1.sec2.sec2.fig1.caption1.p3"></a><p>C. Heart: epicardial calcification in ventricular myocardium (pointed with an arrow), (Haematoxylin-eosin, insert Alizarin RedS staining specific for calcium).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p4" name="article1.body1.sec2.sec2.fig1.caption1.p4"></a><p>D. Control heart. (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p5" name="article1.body1.sec2.sec2.fig1.caption1.p5"></a><p>E. Heart: ventricular myocardium revealed discrete edema and dilatation of subepicardial vessels (CD 31 immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p6" name="article1.body1.sec2.sec2.fig1.caption1.p6"></a><p>F. Tuba uterina revealed high vascularization and focally dilated venules and arterioles (pointed with arrows), (CD 31 immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p7" name="article1.body1.sec2.sec2.fig1.caption1.p7"></a><p>G. Pancreas with focally increased vasculature (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p8" name="article1.body1.sec2.sec2.fig1.caption1.p8"></a><p>H. Control pancreas. (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p9" name="article1.body1.sec2.sec2.fig1.caption1.p9"></a><p>I. Testes with increased and dilated vasculature (pointed with arrows), (CD 31 immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig1.caption1.p10" name="article1.body1.sec2.sec2.fig1.caption1.p10"></a><p>J. Control testes. (CD 31 immunostaining). Bar: A, B, C, D, I,J - 200 µm, G, H, E- 100 µm, F- 500 µm.</p>
<span>doi:10.1371/journal.pone.0000013.g005</span></div><a id="article1.body1.sec2.sec2.p2" name="article1.body1.sec2.sec2.p2"></a><p>At the eighteen months follow-up after the gene transfer major consequences were seen; one mouse developed a hepatocellular carcinoma in the liver and another had a papillary adenocarcinoma in the lungs (<a href="#pone-0000013-g006">Figure 6A, B</a>). Both of these mice had moderate expression levels of hVEGF-A<sub>165</sub> in serum after 1 week (240 and 710 pg/ml). We and others have previously seen spontaneous carcinomas in the liver in many mouse models, especially in old female mice with balb/C background <a href="#pone.0000013-Frith1">[32]</a> and also the transgenic expression of hVEGF-A<sub>165</sub> especially in the lungs was low (mouse endogenous VEGF-A<sub>164</sub> levels were 25 times higher than hVEGF-A<sub>165</sub>). Still, we cannot exclude the possibility that hVEGF-A<sub>165</sub> played a role in the formation of tumors by inducing the growth of dormant tumors or by some other mechanism, especially in the case of hepatocellular carcinoma. In contrast of activated transgenic mice only benign tumors were found in control mice with the same age (wt with Ad gene transfer or transgenic mice without activation); a thecoma in the fallopian tube and an adenoma in the lungs. One hVEGF-A<sub>165</sub> transgenic mouse died spontaneously 16 months after the gene transfer with abdominal cavity full of blood and serum levels of hVEGF-A<sub>165</sub> still over 500 pg/ml. Many changes were seen macroscopically in different tissues of this mouse (<a href="#pone-0000013-g006">Figure 6C–E</a>). Microscopically a pendulating cavernous hemangioma (7 millimetres in diameter) was present in the liver with weak focal hVEGF-A<sub>165</sub> immunoreactivity (<a href="#pone-0000013-g006">Figure 6F–H</a>). Also, the spleen showed a combination of fibrous scars, which were reminiscent of Gandy-Gamna nodules described as a consequence of focal haemorrhage and dilated cystic spaces which were focally filled with blood resembling peliosis (<a href="#pone-0000013-g006">Figure 6I–K</a>). In the same animal the whole paratubary area was highly vascularized and revealed focal hVEGF-A<sub>165</sub> positivity with signs of old haemorrhage and thrombus formation in dilated cystic paratubary spaces. (<a href="#pone-0000013-g006">Figure 6L–N</a>). All of these findings can be connected with local over-expression of hVEGF-A<sub>165</sub>.</p>
<div class="figure" id="pone-0000013-g006"><div class="img"><a name="pone-0000013-g006" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g006&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0000013" data-uri="info:doi/10.1371/journal.pone.0000013.g006"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0000013.g006&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g006/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g006/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g006/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g006/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g006.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0000013.g006/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0000013.g006/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0000013.g006.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 6.  <span>Major changes after 16-months after activation of hVEGF-A<sub>165</sub> expression.</span></strong></p><a id="article1.body1.sec2.sec2.fig2.caption1.p1" name="article1.body1.sec2.sec2.fig2.caption1.p1"></a><p>A. Liver: Encapsulated hepatocellular carcinoma was highly necrotic and focally calcified (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p2" name="article1.body1.sec2.sec2.fig2.caption1.p2"></a><p>B. Lung: Papillary adenocarcinoma. (Haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p3" name="article1.body1.sec2.sec2.fig2.caption1.p3"></a><p>C. Macroscopical changes in liver (box shows the area of the microscopical sections in F–H).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p4" name="article1.body1.sec2.sec2.fig2.caption1.p4"></a><p>D. Macroscopical changes in spleen, control spleen on the left (microscopical sections in I–K).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p5" name="article1.body1.sec2.sec2.fig2.caption1.p5"></a><p>E. Macroscopical changes in paratubarian area (microscopical sections in L–N).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p6" name="article1.body1.sec2.sec2.fig2.caption1.p6"></a><p>F. Cavernous hemangioma featuring focal hyalinization.</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p7" name="article1.body1.sec2.sec2.fig2.caption1.p7"></a><p>G. The same tumor mass area with higher magnification (haematoxylin-eosin).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p8" name="article1.body1.sec2.sec2.fig2.caption1.p8"></a><p>H. Weak focal hVEGF-A<sub>165</sub> immunoreactivity was present in the same area (True Blue as a chromogen), arrows indicate positive cells.</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p9" name="article1.body1.sec2.sec2.fig2.caption1.p9"></a><p>I–K. Fibrous scars formed by collagenous and elastic fibres surrounded by dilated cystic spaces, focally filled with blood and revealing inconsistently CD34 positive lining.</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p10" name="article1.body1.sec2.sec2.fig2.caption1.p10"></a><p>I. Hematoxylin-eosin. (an arrow points to an area shown in K)</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p11" name="article1.body1.sec2.sec2.fig2.caption1.p11"></a><p>J. CD34 immunostaining.</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p12" name="article1.body1.sec2.sec2.fig2.caption1.p12"></a><p>K. The same area as in I with higher magnification (stained with Masson Trichrom).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p13" name="article1.body1.sec2.sec2.fig2.caption1.p13"></a><p>Asterix in I and J indicate the same area.</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p14" name="article1.body1.sec2.sec2.fig2.caption1.p14"></a><p>L. Cystically dilated paratubarian spaces with signs of old haemorrhage and thrombus formation (marked with *), an open circle points to an area which was highly vascularized as shown in M. (CD31 immunostaining) and a box indicates an area which revealed focal hVEGF-A<sub>165</sub> immunopositivity shown in N. (hVEGF-A<sub>165</sub> immunostaining).</p>
<a id="article1.body1.sec2.sec2.fig2.caption1.p15" name="article1.body1.sec2.sec2.fig2.caption1.p15"></a><p>Bar<strong>:</strong> F, I, J - 500 µm, G, H, K - 100 µm, A, B, M, N - 200 µm L - 1000 µm.</p>
<span>doi:10.1371/journal.pone.0000013.g006</span></div><a id="article1.body1.sec2.sec2.p3" name="article1.body1.sec2.sec2.p3"></a><p>In conclusion, we have created a transgenic mouse model which over-expresses hVEGF-A<sub>165</sub> after Cre-protein gene transfer. By using different vectors, tissue specific promoters and local gene transfer techniques hVEGF-A<sub>165</sub> expression can be targeted in desired tissues and cell types in adult mice. In this model the levels of hVEGF-A<sub>165</sub> expression were moderate and typical angiogenetic changes were mostly found in the liver, but also in some other tissues after systemic gene transfer. Most mice were healthy without any major consequences up to 18 months. However, one mouse died spontaneously because of bleeding into abdominal cavity and having liver hemangioma, haemorrhagic paratubarian cystic lesions and spleen peliosis. Also, two mice developed malignant tumors (hepatocellular carcinoma and lung adenocarcinoma). Thus, we concluded that uncontrolled long-term expression of hVEGF-A<sub>165</sub> may cause significant pathological changes in target tissues and tight regulation of the transgene expression seems to be a prerequisite for all therapeutic applications aiming at long-term expression of hVEGF-A<sub>165</sub>.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Methods"></a><h3>Methods</h3>
<h4>Generation of the Cre controlled human VEGF-A<sub>165</sub> expression cassette</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>An oligonucleotide containing restriction sites for Xho I and Sda I was cloned into a Bgl II+Dra II−digested pcDNA3 vector (Invitrogen). The resulting plasmid was named pcDNAmcs. A Sal I and Pst I fragment containing CAG promoter (consisting of the CMV immediate early enhancer and the chicken β–actin promoter) and rabbit β-globin polyA from pCAGGS plasmid (a generious gift from Prof. Jun-ichi Miyazaki) was cloned into XhoI/SdaI cut pcDNAmcs. A loxP site containing an MCS oligo linker was cloned into the EcoRI site of the plasmid. The resulting plasmid was named pCaGGSmcs. A BamHI digested and blunted STOP-cassette (consisting of the SV40 early polyadenylation signal and a splice donor signal <a href="#pone.0000013-Lakso1">[33]</a> from the pBS302 (RIKEN DNA Bank) was incorporated into Pml I site of the pCAGGSmcs. The resulted plasmid was digested with EcoRI and EcoRV and ligated with hVEGF-A<sub>165</sub> cDNA (digested by EcoRI and EcoRV from pCMV-hVEGF-A<sub>165</sub>). The resulting plasmid was named as pFlox (<a href="#pone-0000013-g001">Figure 1</a>) and first tested in NIH-3T3 cells which were tranduced by Cre adenovirus (containing Cre gene under CMV promoter) at MOI 500. 12 h after transduction, cells were transduced with the pFlox plasmid. Medium samples were taken for human VEGF-A ELISA analysis (R&amp;D Systems, Minneapolis, USA) at different time points.</p>


<h4>Experimental animals</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>pFlox plasmid was digested with Sal I/Asc I and the resulting fragment was microinjected into the CD2F1 hybrid mice (Balb/C x DBA2). Transgenic mice were analyzed from tail genomic DNA by PCR using specific primers for hVEGF-A<sub>165</sub> (5′-ccatgaactttctgctgtc-3′ and 5′-tcgtgagattctgccctc-3′) and an internal control gene (ApoB with primers 5′-attgccttagatagtgcc-3′ and 5′-tttgctagatttacacgg-3′), F6 generation mice were used for the experiments. hVEGF-A<sub>165</sub> transgenic mice (n = 31) and control mice without the transgene (n = 10) were injected via tail vein with recombinant E1-partial E3-deleted first generation serotype 5 Cre adenovirus (1×10<sup>9</sup> pfu). Another group of transgenic mice (n = 10) were also injected with saline and served as additional controls. A subgroup of animals were sacrificed 1 to 4 weeks after the gene transfer and the rest of the mice were sacrificed 6 to 18 months after the gene transfer. Diet and water were provided ad libitum. Blood samples were taken and circulating hVEGF-A<sub>165</sub> and endogenous mVEGF-A<sub>164</sub> levels were measured from tail vein plasma samples at various time points after the gene transfer with enzyme-linked immunoassays (R&amp;D; Quantikine, human VEGF-A and mouse VEGF-A). Routine clinical chemistry assays for aspartyl aminotransferase (ASAT) and C-reactive protein (CRP) were done with Ecoline<sup>R</sup>25 (Merck Diagnostica) and Quickread CRP (Orion Diagnostica kits). During gene transfers animals were anesthetized using s.c. fentanyl-fluanisone (3.15 and 10 mg/kg)/midazolam (5 mg/kg). Mice were sacrificed using carbon dioxide. The arterial tree was perfused with PBS. Tissues samples were collected for the analysis of transgene expression <a href="#pone.0000013-Jalkanen1">[34]</a> and either post fixed for 2 h (4% paraformaldehyde) and embedded in paraffin or frozen in liquid nitrogen for RNA and protein analyses. All animal experiments were approved by the Animal Care and use Committee the University of Kuopio.</p>


<h4>MRI and ELISA cross-reaction test</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>Another group of transgenic (n = 8) and control (n = 4) mice were transduced by AdCre or Ad-Tie-Cre or Ad hVEGF-A<sub>165</sub> (1×10<sup>10</sup> pfu/ml) in a total volume of 100 µl distributed into the distal hind limb and into the calf of the left hind limb. Right hind limbs served as controls. Only mice which were transduced by AdCre were followed up with MRI, others were used to evaluate possible cross-reaction by ELISA. MRI was performed at 1, 4, 7, 14, 21, 28, and 42 days after the gene transfer. Mice were anesthetized and positioned with straight-tighten hind limbs inside a surface coil. MRI was performed at 9.4 T vertical Oxford magnet (Oxford Instruments, Eynsham, UK) interfaced to a SMIS console (Surrey Medical Imaging Systems, Guilford, UK). Fat saturation was used in all MRI experiments. T<sub>2</sub>-weighted imaging was performed using a spin echo sequence with two adiabatic refocusing pulses. Total echo time (TE) was 44 ms, repetition time (TR) 2000 ms, resolution 256×128, field-of-view (FOV) 22×22 mm<sup>2</sup> with 4 averages.</p>


<h4>Immunohistochemistry</h4>
<a id="article1.body1.sec3.sec4.p1" name="article1.body1.sec3.sec4.p1"></a><p>For immunohistochemical analysis, serial sections (6 µm) were cut and used for stainings. Sections were routinely stained with hematoxylin-eosin and in selected cases with Masson Trichrom, PAS, and Alizarin Red S method for calcium in order to analyze basic changes in different tissues. Tissue vascularization was assessed by immunostaining with CD34 antibody (HyCult biotechnology BV, clone MEC 14.7, dilution 1:20). Antigen was visualized by avidin-biotin-HRP system (Vectastain ABC kit, Vector Laboratories). Endogenous avidin-biotin activity in liver was blocked by avidin/biotin blocking kit (Avidin/biotin Blocking kit, Vector Laboratories). Additionally, anti-CD 31 rat anti-mouse monoclonal antibody (PECAM-1, BD Pharmingen, clone MEC13.3, 1:50) and LYVE-1 primary rabbit anti-mouse monoclonal antibody (dilution 1:1000) were used to assess the vascular system <a href="#pone.0000013-Cursiefen1">[35]</a>. Both antigens were detected using tyramide signal amplification (TSA Biotin System, PerkinElmer). Hepatocellular proliferation was analyzed by immunostaining for proliferating cell nuclear antigen (PCNA, Neomarkers, clone PC 10, dilution 1:500). Antigen was detected using the DAKO ARK kit (DakoCytomation Denmark A/S, Glostrup, Denmark). Human VEGF-A (polyclonal goat, R&amp;D Systems, 1:500) was detected using avidin-biotin-HRP system (Vectastain ABC kit, Vector Laboratories). The signal was visualized with DAB (Zymed, South San Francisco, CA) or True Blue (KPL, Maryland, USA) as a chromogen. ApoTaq kit was used to evaluate apoptosis in livers after the gene transfer. Number of capillaries and apoptosis in the liver sections was counted in five randomly selected fields at 200x magnification using Olympus AX70 microscope <a href="#pone.0000013-Leppnen1">[26]</a> (Olympus Optical, Japan) and AnalySIS software (Soft Imaging System).</p>


<h4>RT-PCR and protein extractions</h4>
<a id="article1.body1.sec3.sec5.p1" name="article1.body1.sec3.sec5.p1"></a><p>Total RNA was isolated with TRIzol compound (Invitrogen). RNA was DNAse treated and digested before cDNA synthesis with Eco 130I, which cuts the DNA in the middle of the amplification area in order to get rid of possible genomic contamination. cDNA was synthesized from the total RNA with Superscript II (Invitrogen) using random primers. Amplification of the transgene was performed using inner primers for hVEGF-A<sub>165</sub> as described <a href="#pone.0000013-Bhardwaj1">[36]</a>. Proteins were extracted with T-PER Tissue Protein extraction reagent including Halt<span class="small-caps">™</span> protease inhibitors and total protein contents were assayed with BCA<span class="small-caps">™</span> Protein Assay kit (Pierce, USA).</p>


<h4>Statistical analysis</h4>
<a id="article1.body1.sec3.sec6.p1" name="article1.body1.sec3.sec6.p1"></a><p>All statistical analysis were done using modified t-test (SPSS 7.5, SPSS Inc). Data are expressed as mean±SD and value of P&lt;0.05 was considered significant.</p>

</div>





<div><a id="ack" name="ack" toc="ack" title="Acknowledgments"></a><h3>Acknowledgments</h3>
<a id="article1.back1.ack1.p1" name="article1.back1.ack1.p1"></a><p>Authors want to thank Mervi Nieminen, Anne Martikainen, Tiina Koponen, Sari Järveläinen, Seija Sahrio and Tuula Reponen for technical assistance.</p>
</div><div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: SY PL KA JJ. Performed the experiments: IK AM SK HM JN. Analyzed the data: SY PL IK AM JN. Contributed reagents/materials/analysis tools: KA MW LA. Wrote the paper: SY PL IK AM KA</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0000013-Maglione1" id="pone.0000013-Maglione1"></a>Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG (1991) Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA  88: 9267–9271.  <ul class="find" data-citedArticleID="913782" data-doi="10.1073/pnas.88.20.9267"><li><a href="http://dx.doi.org/10.1073/pnas.88.20.9267" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Isolation+of+a+human+placenta+cDNA+coding+for+a+protein+related+to+the+vascular+permeability+factor." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Isolation+of+a+human+placenta+cDNA+coding+for+a+protein+related+to+the+vascular+permeability+factor.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0000013-Joukov1" id="pone.0000013-Joukov1"></a>Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo KA (1996) Novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J  15: 290–298.  <ul class="find" data-citedArticleID="913766"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Novel+vascular+endothelial+growth+factor%2C+VEGF-C%2C+is+a+ligand+for+the+Flt4+%28VEGFR-3%29+and+KDR+%28VEGFR-2%29+receptor+tyrosine+kinases.&amp;auth=&amp;atitle=Novel+vascular+endothelial+growth+factor%2C+VEGF-C%2C+is+a+ligand+for+the+Flt4+%28VEGFR-3%29+and+KDR+%28VEGFR-2%29+receptor+tyrosine+kinases." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Novel+vascular+endothelial+growth+factor%2C+VEGF-C%2C+is+a+ligand+for+the+Flt4+%28VEGFR-3%29+and+KDR+%28VEGFR-2%29+receptor+tyrosine+kinases." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Novel+vascular+endothelial+growth+factor%2C+VEGF-C%2C+is+a+ligand+for+the+Flt4+%28VEGFR-3%29+and+KDR+%28VEGFR-2%29+receptor+tyrosine+kinases.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0000013-Ferrara1" id="pone.0000013-Ferrara1"></a>Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med  9: 669–676.  <ul class="find" data-citedArticleID="913750" data-doi="10.1038/nm0603-669"><li><a href="http://dx.doi.org/10.1038/nm0603-669" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+biology+of+VEGF+and+its+receptors." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+biology+of+VEGF+and+its+receptors.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0000013-YlHerttuala1" id="pone.0000013-YlHerttuala1"></a>Ylä-Herttuala S, Alitalo K (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat Med  9: 694–701.  <ul class="find" data-citedArticleID="913796" data-doi="10.1038/nm0603-694"><li><a href="http://dx.doi.org/10.1038/nm0603-694" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+transfer+as+a+tool+to+induce+therapeutic+vascular+growth." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+transfer+as+a+tool+to+induce+therapeutic+vascular+growth.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0000013-Ferrara2" id="pone.0000013-Ferrara2"></a>Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea , et al.  (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature  380: 439–442.  <ul class="find" data-citedArticleID="913752" data-doi="10.1038/380439a0"><li><a href="http://dx.doi.org/10.1038/380439a0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Heterozygous+embryonic+lethality+induced+by+targeted+inactivation+of+the+VEGF+gene." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Heterozygous+embryonic+lethality+induced+by+targeted+inactivation+of+the+VEGF+gene.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0000013-Carmeliet1" id="pone.0000013-Carmeliet1"></a>Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al.  (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature  380: 435–439.  <ul class="find" data-citedArticleID="913738" data-doi="10.1038/380435a0"><li><a href="http://dx.doi.org/10.1038/380435a0" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Abnormal+blood+vessel+development+and+lethality+in+embryos+lacking+a+single+VEGF+allele." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Abnormal+blood+vessel+development+and+lethality+in+embryos+lacking+a+single+VEGF+allele.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0000013-Gerber1" id="pone.0000013-Gerber1"></a>Gerber H, Hillan KJ, Ryan AM, Kowalski J, Keller G, et al.  (1999) Vegf is required for growth and survival in neonatal mice. Development  126: 1149–1159.  <ul class="find" data-citedArticleID="913756"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Vegf+is+required+for+growth+and+survival+in+neonatal+mice.&amp;auth=&amp;atitle=Vegf+is+required+for+growth+and+survival+in+neonatal+mice." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vegf+is+required+for+growth+and+survival+in+neonatal+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vegf+is+required+for+growth+and+survival+in+neonatal+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0000013-Carmeliet2" id="pone.0000013-Carmeliet2"></a>Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, et al.  (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med  5: 495–502.  <ul class="find" data-citedArticleID="913740"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Impaired+myocardial+angiogenesis+and+ischemic+cardiomyopathy+in+mice+lacking+the+vascular+endothelial+growth+factor+isoforms+VEGF164+and+VEGF188.&amp;auth=&amp;atitle=Impaired+myocardial+angiogenesis+and+ischemic+cardiomyopathy+in+mice+lacking+the+vascular+endothelial+growth+factor+isoforms+VEGF164+and+VEGF188." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Impaired+myocardial+angiogenesis+and+ischemic+cardiomyopathy+in+mice+lacking+the+vascular+endothelial+growth+factor+isoforms+VEGF164+and+VEGF188." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Impaired+myocardial+angiogenesis+and+ischemic+cardiomyopathy+in+mice+lacking+the+vascular+endothelial+growth+factor+isoforms+VEGF164+and+VEGF188.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0000013-Krkkainen1" id="pone.0000013-Krkkainen1"></a>Kärkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, et al.  (2001) Model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA  98: 12677–12682.  <ul class="find" data-citedArticleID="913770" data-doi="10.1073/pnas.221449198"><li><a href="http://dx.doi.org/10.1073/pnas.221449198" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Model+for+gene+therapy+of+human+hereditary+lymphedema." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Model+for+gene+therapy+of+human+hereditary+lymphedema.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0000013-Krkkainen2" id="pone.0000013-Krkkainen2"></a>Kärkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, et al.  (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol  5: 74–80.  <ul class="find" data-citedArticleID="913772" data-doi="10.1038/ni1013"><li><a href="http://dx.doi.org/10.1038/ni1013" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vascular+endothelial+growth+factor+C+is+required+for+sprouting+of+the+first+lymphatic+vessels+from+embryonic+veins." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vascular+endothelial+growth+factor+C+is+required+for+sprouting+of+the+first+lymphatic+vessels+from+embryonic+veins.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0000013-Bellomo1" id="pone.0000013-Bellomo1"></a>Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, et al.  (2000) Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res  86: E29–35.  <ul class="find" data-citedArticleID="913732" data-doi="10.1161/01.res.86.2.e29"><li><a href="http://dx.doi.org/10.1161/01.res.86.2.e29" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mice+lacking+the+vascular+endothelial+growth+factor-B+gene+%28Vegfb%29+have+smaller+hearts%2C+dysfunctional+coronary+vasculature%2C+and+impaired+recovery+from+cardiac+ischemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mice+lacking+the+vascular+endothelial+growth+factor-B+gene+%28Vegfb%29+have+smaller+hearts%2C+dysfunctional+coronary+vasculature%2C+and+impaired+recovery+from+cardiac+ischemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0000013-Carmeliet3" id="pone.0000013-Carmeliet3"></a>Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, et al.  (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med  7: 575–583.  <ul class="find" data-citedArticleID="913742"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Synergism+between+vascular+endothelial+growth+factor+and+placental+growth+factor+contributes+to+angiogenesis+and+plasma+extravasation+in+pathological+conditions.&amp;auth=&amp;atitle=Synergism+between+vascular+endothelial+growth+factor+and+placental+growth+factor+contributes+to+angiogenesis+and+plasma+extravasation+in+pathological+conditions." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Synergism+between+vascular+endothelial+growth+factor+and+placental+growth+factor+contributes+to+angiogenesis+and+plasma+extravasation+in+pathological+conditions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Synergism+between+vascular+endothelial+growth+factor+and+placental+growth+factor+contributes+to+angiogenesis+and+plasma+extravasation+in+pathological+conditions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0000013-Baldwin1" id="pone.0000013-Baldwin1"></a>Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, et al.  (2005) Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol  25: 2441–2449.  <ul class="find" data-citedArticleID="913730" data-doi="10.1128/mcb.25.6.2441-2449.2005"><li><a href="http://dx.doi.org/10.1128/mcb.25.6.2441-2449.2005" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vascular+endothelial+growth+factor+D+is+dispensable+for+development+of+the+lymphatic+system." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vascular+endothelial+growth+factor+D+is+dispensable+for+development+of+the+lymphatic+system.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0000013-Vogel1" id="pone.0000013-Vogel1"></a>Vogel J, Gehrig M, Kuschinsky W, Marti HH (2004) Massive inborn angiogenesis in the brain scarcely raises cerebral blood flow. J Cereb Blood Flow Metab  24: 849–859.  <ul class="find" data-citedArticleID="913794" data-doi="10.1097/01.wcb.0000126564.89011.11"><li><a href="http://dx.doi.org/10.1097/01.wcb.0000126564.89011.11" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Massive+inborn+angiogenesis+in+the+brain+scarcely+raises+cerebral+blood+flow." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Massive+inborn+angiogenesis+in+the+brain+scarcely+raises+cerebral+blood+flow.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0000013-Detmar1" id="pone.0000013-Detmar1"></a>Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, et al.  (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice J Invest Dermatol  111: 1–6.  <ul class="find" data-citedArticleID="913746" data-doi="10.1046/j.1523-1747.1998.00262.x"><li><a href="http://dx.doi.org/10.1046/j.1523-1747.1998.00262.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Increased+microvascular+density+and+enhanced+leukocyte+rolling+and+adhesion+in+the+skin+of+VEGF+transgenic+mice" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Increased+microvascular+density+and+enhanced+leukocyte+rolling+and+adhesion+in+the+skin+of+VEGF+transgenic+mice%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">16.
              </span><a name="pone.0000013-Zeng1" id="pone.0000013-Zeng1"></a>Zeng X, Wert SE, Federici R, Peters KG, Whitsett JA (1998) VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo. Dev Dyn  211: 215–227.  <ul class="find" data-citedArticleID="913800" data-doi="10.1002/(sici)1097-0177(199803)211:3<215::aid-aja3&gt;3.0.co;2-k"><li><a href="http://dx.doi.org/10.1002/(sici)1097-0177(199803)211:3<215::aid-aja3&gt;3.0.co;2-k" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=VEGF+enhances+pulmonary+vasculogenesis+and+disrupts+lung+morphogenesis+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22VEGF+enhances+pulmonary+vasculogenesis+and+disrupts+lung+morphogenesis+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">17.
              </span><a name="pone.0000013-Okamoto1" id="pone.0000013-Okamoto1"></a>Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle , et al.  (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization Am J Pathol  151: 281–291.  <ul class="find" data-citedArticleID="913788" data-doi="10.1097/00006982-199805000-00034"><li><a href="http://dx.doi.org/10.1097/00006982-199805000-00034" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Transgenic+mice+with+increased+expression+of+vascular+endothelial+growth+factor+in+the+retina%3A+a+new+model+of+intraretinal+and+subretinal+neovascularization" target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Transgenic+mice+with+increased+expression+of+vascular+endothelial+growth+factor+in+the+retina%3A+a+new+model+of+intraretinal+and+subretinal+neovascularization%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">18.
              </span><a name="pone.0000013-Dor1" id="pone.0000013-Dor1"></a>Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, et al.  (2002) Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J  21: 1939–1947.  <ul class="find" data-citedArticleID="913748" data-doi="10.1093/emboj/21.8.1939"><li><a href="http://dx.doi.org/10.1093/emboj/21.8.1939" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Conditional+switching+of+VEGF+provides+new+insights+into+adult+neovascularization+and+pro-angiogenic+therapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Conditional+switching+of+VEGF+provides+new+insights+into+adult+neovascularization+and+pro-angiogenic+therapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">19.
              </span><a name="pone.0000013-Odorisio1" id="pone.0000013-Odorisio1"></a>Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, et al.  (2002) Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci  115: 2559–2567.  <ul class="find" data-citedArticleID="913786"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Mice+overexpressing+placenta+growth+factor+exhibit+increased+vascularization+and+vessel+permeability.&amp;auth=&amp;atitle=Mice+overexpressing+placenta+growth+factor+exhibit+increased+vascularization+and+vessel+permeability." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Mice+overexpressing+placenta+growth+factor+exhibit+increased+vascularization+and+vessel+permeability." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Mice+overexpressing+placenta+growth+factor+exhibit+increased+vascularization+and+vessel+permeability.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">20.
              </span><a name="pone.0000013-Jeltsch1" id="pone.0000013-Jeltsch1"></a>Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, et al.  (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science  276: 1423–1425.  <ul class="find" data-citedArticleID="913764" data-doi="10.1126/science.276.5317.1423"><li><a href="http://dx.doi.org/10.1126/science.276.5317.1423" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Hyperplasia+of+lymphatic+vessels+in+VEGF-C+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Hyperplasia+of+lymphatic+vessels+in+VEGF-C+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">21.
              </span><a name="pone.0000013-Veikkola1" id="pone.0000013-Veikkola1"></a>Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, et al.  (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J  20: 1223–1231.  <ul class="find" data-citedArticleID="913792" data-doi="10.1093/emboj/20.6.1223"><li><a href="http://dx.doi.org/10.1093/emboj/20.6.1223" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Signalling+via+vascular+endothelial+growth+factor+receptor-3+is+sufficient+for+lymphangiogenesis+in+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Signalling+via+vascular+endothelial+growth+factor+receptor-3+is+sufficient+for+lymphangiogenesis+in+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">22.
              </span><a name="pone.0000013-Mandriota1" id="pone.0000013-Mandriota1"></a>Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, et al.  (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J  20: 672–682.  <ul class="find" data-citedArticleID="913784" data-doi="10.1093/emboj/20.4.672"><li><a href="http://dx.doi.org/10.1093/emboj/20.4.672" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vascular+endothelial+growth+factor-C-mediated+lymphangiogenesis+promotes+tumour+metastasis." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vascular+endothelial+growth+factor-C-mediated+lymphangiogenesis+promotes+tumour+metastasis.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">23.
              </span><a name="pone.0000013-Laitinen1" id="pone.0000013-Laitinen1"></a>Laitinen M, Mäkinen K, Manninen H, Matsi P, Kossila M, et al.  (1998) Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther  9: 1481–1486.  <ul class="find" data-citedArticleID="913774" data-doi="10.1089/hum.1998.9.10-1481"><li><a href="http://dx.doi.org/10.1089/hum.1998.9.10-1481" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adenovirus-mediated+gene+transfer+to+lower+limb+artery+of+patients+with+chronic+critical+leg+ischemia." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adenovirus-mediated+gene+transfer+to+lower+limb+artery+of+patients+with+chronic+critical+leg+ischemia.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">24.
              </span><a name="pone.0000013-Puumalainen1" id="pone.0000013-Puumalainen1"></a>Puumalainen AM, Vapalahti M, Agrawal RS, Kossila M, Laukkanen J, et al.  (1998) Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenoviruses. Hum Gene Ther  9: 1769–1774.  <ul class="find" data-citedArticleID="913790" data-doi="10.1089/hum.1998.9.12-1769"><li><a href="http://dx.doi.org/10.1089/hum.1998.9.12-1769" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Beta-galactosidase+gene+transfer+to+human+malignant+glioma+in+vivo+using+replication-deficient+retroviruses+and+adenoviruses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Beta-galactosidase+gene+transfer+to+human+malignant+glioma+in+vivo+using+replication-deficient+retroviruses+and+adenoviruses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">25.
              </span><a name="pone.0000013-Kilby1" id="pone.0000013-Kilby1"></a>Kilby NJ, Snaith MR, Murray JA (1993) Site-specific recombinases: tools for genome engineering. Trends Genet  9: 413–21.  <ul class="find" data-citedArticleID="913768" data-doi="10.1016/0168-9525(93)90104-p"><li><a href="http://dx.doi.org/10.1016/0168-9525(93)90104-p" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Site-specific+recombinases%3A+tools+for+genome+engineering." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Site-specific+recombinases%3A+tools+for+genome+engineering.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">26.
              </span><a name="pone.0000013-Leppnen1" id="pone.0000013-Leppnen1"></a>Leppänen P, Koota S, Kholová I, Koponen J, Fieber C, et al.  (2005) Gene transfers of VEGF-A, VEGF-B, VEGF-C and VEGF-D have no effects on atherosclerosis in hypercholesterolemic LDL-receptor/ApoB48- deficient mice. Circulation  112: 1347–1352.  <ul class="find" data-citedArticleID="913780" data-doi="10.1016/s1567-5688(07)71170-4"><li><a href="http://dx.doi.org/10.1016/s1567-5688(07)71170-4" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Gene+transfers+of+VEGF-A%2C+VEGF-B%2C+VEGF-C+and+VEGF-D+have+no+effects+on+atherosclerosis+in+hypercholesterolemic+LDL-receptor%2FApoB48-+deficient+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Gene+transfers+of+VEGF-A%2C+VEGF-B%2C+VEGF-C+and+VEGF-D+have+no+effects+on+atherosclerosis+in+hypercholesterolemic+LDL-receptor%2FApoB48-+deficient+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">27.
              </span><a name="pone.0000013-Hiltunen1" id="pone.0000013-Hiltunen1"></a>Hiltunen MO, Turunen MP, Turunen AM, Rissanen T, Ruuskanen M, et al.  (2000) Biodistribution of adenoviral vector to nontarget tissues after local in vivo gene transfer to arterial wall using intravascular and periadventitial gene delivery methods. FASEB J  14: 2230–2236.  <ul class="find" data-citedArticleID="913758" data-doi="10.1096/fj.00-0145com"><li><a href="http://dx.doi.org/10.1096/fj.00-0145com" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Biodistribution+of+adenoviral+vector+to+nontarget+tissues+after+local+in+vivo+gene+transfer+to+arterial+wall+using+intravascular+and+periadventitial+gene+delivery+methods." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Biodistribution+of+adenoviral+vector+to+nontarget+tissues+after+local+in+vivo+gene+transfer+to+arterial+wall+using+intravascular+and+periadventitial+gene+delivery+methods.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">28.
              </span><a name="pone.0000013-YlHerttuala2" id="pone.0000013-YlHerttuala2"></a>Ylä-Herttuala S, Martin JF (2000) Cardiovascular gene therapy. Lancet  355: 213–22.  <ul class="find" data-citedArticleID="913798" data-doi="10.1016/s0140-6736(99)04180-x"><li><a href="http://dx.doi.org/10.1016/s0140-6736(99)04180-x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Cardiovascular+gene+therapy." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Cardiovascular+gene+therapy.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">29.
              </span><a name="pone.0000013-Belteki1" id="pone.0000013-Belteki1"></a>Belteki G, Haigh J, Kabacs N, Haigh K, Sison K, et al.  (2005) Conditional and indusible transgene expression in mice through combinatorial use of cre-mediated recombination and tetracycline induction. Nucleic Acid Res  33: E51.  <ul class="find" data-citedArticleID="913734" data-doi="10.1093/nar/gni051"><li><a href="http://dx.doi.org/10.1093/nar/gni051" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Conditional+and+indusible+transgene+expression+in+mice+through+combinatorial+use+of+cre-mediated+recombination+and+tetracycline+induction." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Conditional+and+indusible+transgene+expression+in+mice+through+combinatorial+use+of+cre-mediated+recombination+and+tetracycline+induction.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">30.
              </span><a name="pone.0000013-LeCouter1" id="pone.0000013-LeCouter1"></a>LeCouter J, Moritz DR, Li B, Phillips GL, Liang XH, et al.  (2003) Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science  299: 890–893.  <ul class="find" data-citedArticleID="913778" data-doi="10.1126/science.1079562"><li><a href="http://dx.doi.org/10.1126/science.1079562" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Angiogenesis-independent+endothelial+protection+of+liver%3A+role+of+VEGFR-1." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Angiogenesis-independent+endothelial+protection+of+liver%3A+role+of+VEGFR-1.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">31.
              </span><a name="pone.0000013-Hiltunen2" id="pone.0000013-Hiltunen2"></a>Hiltunen MO, Ruuskanen M, Huuskonen J, Mähönen AJ, Ahonen M, et al.  (2003) Adenovirus-mediated VEGF-A gene transfer induces bone formation in vivo. FASEB J  17: 1147–1149.  <ul class="find" data-citedArticleID="913760" data-doi="10.1096/fj.02-0514fje"><li><a href="http://dx.doi.org/10.1096/fj.02-0514fje" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adenovirus-mediated+VEGF-A+gene+transfer+induces+bone+formation+in+vivo." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adenovirus-mediated+VEGF-A+gene+transfer+induces+bone+formation+in+vivo.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">32.
              </span><a name="pone.0000013-Frith1" id="pone.0000013-Frith1"></a>Frith CH, Wiley L (1982) Spontaneous hepatocellular neoplasms and hepatic hemangiosarcomas in several strains of mice. Lab Lab Anim Sci  32: 157–62.  <ul class="find" data-citedArticleID="913754"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Spontaneous+hepatocellular+neoplasms+and+hepatic+hemangiosarcomas+in+several+strains+of+mice.&amp;auth=&amp;atitle=Spontaneous+hepatocellular+neoplasms+and+hepatic+hemangiosarcomas+in+several+strains+of+mice." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Spontaneous+hepatocellular+neoplasms+and+hepatic+hemangiosarcomas+in+several+strains+of+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Spontaneous+hepatocellular+neoplasms+and+hepatic+hemangiosarcomas+in+several+strains+of+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">33.
              </span><a name="pone.0000013-Lakso1" id="pone.0000013-Lakso1"></a>Lakso M, Sauer B, Mosinger B Jr, Lee EJ, Manning RW, et al.  (1992) Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA  89: 6232–6236.  <ul class="find" data-citedArticleID="913776" data-doi="10.1073/pnas.89.14.6232"><li><a href="http://dx.doi.org/10.1073/pnas.89.14.6232" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Targeted+oncogene+activation+by+site-specific+recombination+in+transgenic+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Targeted+oncogene+activation+by+site-specific+recombination+in+transgenic+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">34.
              </span><a name="pone.0000013-Jalkanen1" id="pone.0000013-Jalkanen1"></a>Jalkanen J, Leppänen P, Narvanen O, Greaves DR, Ylä-Herttuala S (2003) Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice. Atherosclerosis  169: 95–103.  <ul class="find" data-citedArticleID="913762" data-doi="10.1016/s0021-9150(03)00155-2"><li><a href="http://dx.doi.org/10.1016/s0021-9150(03)00155-2" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Adenovirus-mediated+gene+transfer+of+a+secreted+decoy+human+macrophage+scavenger+receptor+%28SR-AI%29+in+LDL+receptor+knock-out+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Adenovirus-mediated+gene+transfer+of+a+secreted+decoy+human+macrophage+scavenger+receptor+%28SR-AI%29+in+LDL+receptor+knock-out+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">35.
              </span><a name="pone.0000013-Cursiefen1" id="pone.0000013-Cursiefen1"></a>Cursiefen C, Schlotzer-Schrehardt U, Kuchle M, Sorokin L, Breiteneder-Geleff S, et al.  (2002) Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci  43: 2127–2135.  <ul class="find" data-citedArticleID="913744"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Lymphatic+vessels+in+vascularized+human+corneas%3A+immunohistochemical+investigation+using+LYVE-1+and+podoplanin.&amp;auth=&amp;atitle=Lymphatic+vessels+in+vascularized+human+corneas%3A+immunohistochemical+investigation+using+LYVE-1+and+podoplanin." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Lymphatic+vessels+in+vascularized+human+corneas%3A+immunohistochemical+investigation+using+LYVE-1+and+podoplanin." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Lymphatic+vessels+in+vascularized+human+corneas%3A+immunohistochemical+investigation+using+LYVE-1+and+podoplanin.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">36.
              </span><a name="pone.0000013-Bhardwaj1" id="pone.0000013-Bhardwaj1"></a>Bhardwaj S, Roy H, Gruchala M, Viita H, Kholova I, et al.  (2003) Angiogenic Responses of Vascular Endothelial Growth Factors in Periadventitial Tissue. Hum Gene Ther  14: 1451–1462.  <ul class="find" data-citedArticleID="913736" data-doi="10.1089/104303403769211664"><li><a href="http://dx.doi.org/10.1089/104303403769211664" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Angiogenic+Responses+of+Vascular+Endothelial+Growth+Factors+in+Periadventitial+Tissue." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Angiogenic+Responses+of+Vascular+Endothelial+Growth+Factors+in+Periadventitial+Tissue.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.XML" value="107144"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.PDF" value="511438"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g001.PNG_L" value="622956"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g001.PNG_M" value="57118"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g001.PNG_S" value="2710"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g001.TIF" value="760830"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g001.PNG_I" value="18970"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g002.PNG_L" value="1921264"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g002.PNG_M" value="103388"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g002.PNG_S" value="3257"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g002.TIF" value="1824768"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g002.PNG_I" value="34268"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g003.PNG_L" value="1316009"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g003.PNG_M" value="50540"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g003.PNG_S" value="2613"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g003.TIF" value="1369834"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g003.PNG_I" value="16813"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t001.PNG_L" value="80427"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t001.PNG_M" value="12503"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t001.PNG_S" value="1785"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t001.TIF" value="4540598"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t001.PNG_I" value="5560"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t002.PNG_L" value="77502"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t002.PNG_M" value="12241"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t002.PNG_S" value="1692"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t002.TIF" value="5218780"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.t002.PNG_I" value="5578"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g004.PNG_L" value="1136190"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g004.PNG_M" value="216564"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g004.PNG_S" value="5628"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g004.TIF" value="1543324"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g004.PNG_I" value="70570"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g005.PNG_L" value="2414695"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g005.PNG_M" value="575149"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g005.PNG_S" value="11660"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g005.TIF" value="3342952"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g005.PNG_I" value="182275"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g006.PNG_L" value="3239722"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g006.PNG_M" value="475841"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g006.PNG_S" value="18520"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g006.TIF" value="4392274"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0000013.g006.PNG_I" value="281105"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000013&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0000013" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0000013&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0000013&volume=&issue=&title=Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice&author_name=Pia%20Lepp%C3%A4nen%2C%20Ivana%20Kholov%C3%A1%2C%20Anssi%20J.%20M%C3%A4h%C3%B6nen%2C%20Kari%20Airenne%2C%20Suvi%20Koota%2C%20Hannu%20Mansukoski%2C%20Johanna%20N%C3%A4rv%C3%A4inen%2C%20Maria%20Wirzenius%2C%20Leena%20Alhonen%2C%20Juhani%20J%C3%A4nne%2C%20Kari%20Alitalo%2C%20Seppo%20Yl%C3%A4-Herttuala&start_page=1&end_page=8" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0000013" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013&amp;t=Short%20and%20Long-Term%20Effects%20of%20hVEGF-A165%20in%20Cre-Activated%20Transgenic%20Mice" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013&title=Short%20and%20Long-Term%20Effects%20of%20hVEGF-A165%20in%20Cre-Activated%20Transgenic%20Mice&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013&amp;title=Short%20and%20Long-Term%20Effects%20of%20hVEGF-A165%20in%20Cre-Activated%20Transgenic%20Mice" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0000013&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Short and Long-Term Effects of hVEGF-A165 in Cre-Activated Transgenic Mice';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0000013';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Short%20and%20Long-Term%20Effects%20of%20hVEGF-A165%20in%20Cre-Activated%20Transgenic%20Mice http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0000013" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0000013" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">














          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Adenocarcinoma+of+the+lung%22" title="Search for articles in the subject area:'Adenocarcinoma of the lung'"><div class="flagText">Adenocarcinoma of the lung</div></a>
              <div data-categoryid="32837" data-articleid="22866"
                   data-categoryname="Adenocarcinoma of the lung"
                   class="flagImage" title="Flag 'Adenocarcinoma of the lung' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Enzyme-linked+immunoassays%22" title="Search for articles in the subject area:'Enzyme-linked immunoassays'"><div class="flagText">Enzyme-linked immunoassays</div></a>
              <div data-categoryid="20331" data-articleid="22866"
                   data-categoryname="Enzyme-linked immunoassays"
                   class="flagImage" title="Flag 'Enzyme-linked immunoassays' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Gene+transfer%22" title="Search for articles in the subject area:'Gene transfer'"><div class="flagText">Gene transfer</div></a>
              <div data-categoryid="19255" data-articleid="22866"
                   data-categoryname="Gene transfer"
                   class="flagImage" title="Flag 'Gene transfer' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Heart%22" title="Search for articles in the subject area:'Heart'"><div class="flagText">Heart</div></a>
              <div data-categoryid="47373" data-articleid="22866"
                   data-categoryname="Heart"
                   class="flagImage" title="Flag 'Heart' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Magnetic+resonance+imaging%22" title="Search for articles in the subject area:'Magnetic resonance imaging'"><div class="flagText">Magnetic resonance imaging</div></a>
              <div data-categoryid="46177" data-articleid="22866"
                   data-categoryname="Magnetic resonance imaging"
                   class="flagImage" title="Flag 'Magnetic resonance imaging' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Mouse+models%22" title="Search for articles in the subject area:'Mouse models'"><div class="flagText">Mouse models</div></a>
              <div data-categoryid="32069" data-articleid="22866"
                   data-categoryname="Mouse models"
                   class="flagImage" title="Flag 'Mouse models' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Spleen%22" title="Search for articles in the subject area:'Spleen'"><div class="flagText">Spleen</div></a>
              <div data-categoryid="47367" data-articleid="22866"
                   data-categoryname="Spleen"
                   class="flagImage" title="Flag 'Spleen' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Transgenic+animals%22" title="Search for articles in the subject area:'Transgenic animals'"><div class="flagText">Transgenic animals</div></a>
              <div data-categoryid="33751" data-articleid="22866"
                   data-categoryname="Transgenic animals"
                   class="flagImage" title="Flag 'Transgenic animals' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=7515'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=9453'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=3332&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
